Thymosin Alpha-1 (Tα1) Research Overview

What Thymosin Alpha-1 Is

Thymosin Alpha-1 (Tα1, sometimes written TA1) is a 28-amino-acid peptide first characterised from thymosin fraction 5, a partially purified thymic extract, in 1977. The material supplied for laboratory work is produced synthetically. It is described by its defined sequence and by the endpoints published research has examined, not by any application.

• Sequence: Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH
• Molecular weight: approximately 3,108 Da (28 residues)
• N-terminal modification: acetylated, a feature reported as relevant to activity in published assays
• Class: synthetic thymic peptide research material
• Distinct from: Thymalin (a thymic peptide preparation rather than one isolated sequence) and the unrelated Thymosin Beta-4 family

Because Tα1 is a single defined sequence, it is the thymic peptide most frequently used as a reference material in laboratory immunology work — analytical identity can be confirmed against a known sequence, which is not the case for multi-component thymic preparations.

Receptor-Signalling Endpoints

The most frequently reported innate-signalling endpoint for Tα1 is engagement of Toll-like receptors — TLR9 and, in some reports, TLR2 — on dendritic cell populations in culture. Published assays describe MyD88/IRAK/TRAF6-associated NF-κB readouts and IRF7-associated type I interferon measurements downstream of that engagement, together with dendritic-cell maturation markers and co-stimulatory molecule expression.

T-Cell and Cytokine Readouts

A second body of laboratory work measures adaptive-compartment markers. Reported endpoints include surface marker expression (CD3, CD4, CD8, CD25) on thymocytes and peripheral T-cell populations, interleukin-2 production and IL-2 receptor expression, and cytokine ratios used to characterise Th1-associated versus Th2-associated profiles in defined culture systems.

Comparative Position

Within thymic peptide research, Tα1 occupies the single-sequence position: one acetylated 28-residue chain with a known molecular weight. Thymalin is characterised in the literature as a preparation containing multiple thymic peptide components, so comparisons between the two are structural and analytical rather than interchangeable. Thymosin Beta-4 and its TB-500 fragment belong to a separate structural family with different reported endpoints. Researchers selecting a reference material generally evaluate our Thymosin Alpha-1 research material against those distinctions.

Limitations of the Available Literature

The published Tα1 record is uneven. Much of it comes from small-cohort work, manufacturer dossiers, or extrapolation from structurally related peptides, and reported frequencies and effect sizes should be treated as informative rather than definitive. Assay conditions vary widely between laboratories — receptor-expression levels, culture media, and readout timing all shift the measured response — so cross-study comparison is difficult. There is no large standardised dataset for this peptide comparable to what exists for well-characterised reference compounds, and published figures should be read with that gap in mind. Handling is a further confounder: a meaningful share of anomalous laboratory results traces to reconstitution and storage variance rather than to the peptide itself, which is why lot documentation should be recorded for every vial used in an experiment.

References

• Ancell CD et al., "Thymosin alpha-1" (2001), PMID 11381492
• Dominari A et al., "Thymosin alpha 1: A comprehensive review of the literature" (2020), PMID 33362999
• Simonova MA et al., "Aging and Thymosin Alpha-1" (2025), PMID 41373628